KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Goodwill & Intangibles (2016 - 2025)

Gsk (GSK) has 9 years of Goodwill & Intangibles data on record, last reported at $19.9 billion in Q4 2024.

  • For Q4 2024, Goodwill & Intangibles rose 135.57% year-over-year to $19.9 billion; the TTM value through Dec 2024 reached $19.9 billion, up 135.57%, while the annual FY2024 figure was $19.8 billion, 134.1% up from the prior year.
  • Goodwill & Intangibles reached $19.9 billion in Q4 2024 per GSK's latest filing, up from $8.5 billion in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $25.1 billion in Q4 2022 and bottomed at $8.5 billion in Q4 2023.
  • Average Goodwill & Intangibles over 5 years is $16.3 billion, with a median of $14.2 billion recorded in 2021.
  • Peak YoY movement for Goodwill & Intangibles: plummeted 66.26% in 2023, then surged 135.57% in 2024.
  • A 5-year view of Goodwill & Intangibles shows it stood at $14.0 billion in 2020, then rose by 1.65% to $14.2 billion in 2021, then skyrocketed by 76.17% to $25.1 billion in 2022, then tumbled by 66.26% to $8.5 billion in 2023, then soared by 135.57% to $19.9 billion in 2024.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $19.9 billion in Q4 2024, $8.5 billion in Q4 2023, and $25.1 billion in Q4 2022.